Posted inPharma Marketing
Is AI the Secret to Pharma’s High-Engagement CME Video Strategy?
Abstract In the fast-paced, information-saturated world of oncology in the US, continuous medical education (CME)…
Posted inPharma Marketing
From Biomarkers to Breakthroughs: Is Your Pharma Storytelling Resonating with the Human Heart of Oncology?
Abstract In the complex and data-rich world of oncology, scientific communication is often characterized by…
Posted inPharma Marketing
How AI is Orchestrating the Cancer Care Journey from Awareness to Adherence
Abstract The cancer care journey is a complex, emotionally charged, and often protracted experience for…
Posted inPharma Marketing
How Real-World Data and AI are Redefining Oncology Marketing in the US?
Abstract The oncology landscape in the United States is undergoing an unprecedented transformation, driven by…
Posted inPharma Marketing
Beyond the Hype: 5 AI Use Cases Pharma Marketers Are Piloting in 2025
Abstract The pharmaceutical industry, especially within the highly specialized field of oncology in the US,…
Posted inPharma Marketing
Can Precision Marketing with AI Revolutionize Pharma Like Precision Medicine Transformed Oncology?
Abstract Precision Medicine has fundamentally reshaped oncology, moving beyond one-size-fits-all treatments to deliver highly targeted…
Posted inPharma Marketing
Binge-Worthy Insights: Is Your Pharma Engagement as Compelling as Netflix? What Oncologists Really Want
Abstract In an era saturated with information and personalized digital experiences, healthcare professionals (HCPs), particularly…
Posted inPharma Marketing
Beyond Remission: Are Pharma and Physicians Ready for the Long-Term Journey of Immunotherapy and Targeted Therapy Survivors?
Abstract The advent of immunotherapy (IO) and targeted therapies (TT) has dramatically reshaped the landscape…
Posted inPharma Marketing
Are You Losing Doctors’ Attention? Re-Engage with AI in Oncology Marketing
Abstract The oncology landscape in the US is rapidly evolving, marked by scientific breakthroughs, an…
Posted inPharma Marketing
Why 70% of Oncology Drug Launches Falter? How AI-Powered Digital Marketing Platforms, like Hidoc, are Rewriting the Rules for US Pharma
Abstract The oncology drug development landscape is notoriously challenging, with a staggering 70% of new…